| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| syntetisk antiøstrogen |
Is a |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| gonadotropinudløsende hormon-analog |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Product containing somatostatin analog (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Nafarelin (as nafarelin acetate) 200 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Product containing buserelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| buserelin 1 mg/ml injektionsvæske, opløsning, hætteglas a 5,5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Buserelin (as buserelin acetate) 100 microgram/actuation nasal spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Product containing precisely goserelin (as goserelin acetate) 3.6 milligram/1 each prolonged-release subcutaneous implant (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| octreotid 50 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| octreotid 100 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| octreotid 500 µg/ml injektionsvæske, opløsning, ampul a 1 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| octreotid 200 µg/ml injektionsvæske, opløsning, hætteglas a 5 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| octreotid 10 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| octreotid 20 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| octreotid 30 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| leuprorelinacetat 3,75 mg pulver til injektionsvæske, rekonstitution, + diluent + sæt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| leuprorelinacetat 11,25 mg pulver til injektionsvæske, opløsning, rekonstitution + diluent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Product containing triptorelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| triptorelin 4,2 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Product containing lanreotide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| lanreotid 30 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Product containing leuprorelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| buserelin 150 µg spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Product containing goserelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| goserelinacetatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Product containing octreotide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Octreotide acetate preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Product containing nafarelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| nafarelinacetatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Product containing histrelin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| histrelinacetatpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| syntetisk hormonpræparat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
1 |
| Product containing somatostatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| leuprorelinacetat 65 mg implantat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| triptorelin 3,75 mg pulver og solvens til injektionsvæskei fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| triptorelin 15 mg pulver og diluent til injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Buserelin acetate [endometriosis] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| leuprorelinacetat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| lanreotid 60 mg/0,3 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| lanreotid 90 mg/0,3 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| lanreotid 120 mg/0,5 ml i fyldt injektionssprøjte |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| goserelinacetat implantat, i fyldt injektionssprøjte a 10,8 mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Octreotide acetate 20mg depot injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Octreotide acetate 10mg depot injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Octreotide acetate 30mg depot injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Nafarelin acetate 2mg solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Nafarelin acetate 2mg/mL solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| triptorelinpamoat 3,75 mg hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| triptorelinpamoat 11,25 mg hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| leuprorelinacetat 15 mg pulver og solvens til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| leuprorelinacetat 5 mg/ml injektionsvæske, opløsning, ampul a 0,2 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| leuprorelinacetat 3,75 mg hætteglas pulver |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| leuprorelinacetat 7,5 mg pulver til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| leuprorelinacetat 22,5 mg pulver til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| leuprorelinacetat 30 mg pulver til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| leuprorelinacetat 11,25 mg pulver til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Octreotide acetate 1mg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Octreotide acetate 100mcg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Octreotide acetate 200mcg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Octreotide acetate 500mcg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Octreotide acetate 50mcg/mL injection solution ampule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| goserelinacetat 3,6 mg implantat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Lanreotide acetate 30mg/vial injection suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| histrelin 120 µg/0,6 ml (200 µg/ml peptidbase) injektionsvæske, opløsning, hætteglas a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| histrelin 600 µg/0,6 ml (1000 µg/ml peptidbase) injektionsvæske, opløsning, hætteglas a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| histrelin 300 µg/0,6 ml (500 µg/ml peptidbase) injektionsvæske, opløsning, hætteglas a 0,6 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| kontraceptionsmiddel |
Is a |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| histrelin 50 mg implantat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| leuprorelinacetat 45 mg pulver til injektionsvæske, suspension, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Alfaprostol |
Is a |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Fenprostalene |
Is a |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Tetracosactide |
Is a |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Cyclofenil (substance) |
Is a |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| octreotid 1 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Melanocyte stimulating hormone analog (substance) |
Is a |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Poisoning caused by synthetic hormone substitute |
Causative agent |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
1 |
| Ornipressin |
Is a |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Desmopressin |
Is a |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Desmopressin acetate |
Is a |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Medrogestone (substance) |
Is a |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
| Tetracosactide acetate |
Is a |
False |
syntetisk hormonmiddel |
Inferred relationship |
Some |
|
FHIR